Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)

Troels Thim; Michael Maeng; Jens Flensted Lassen; Anne Kjer Kaltoft; Lisette Okkels Jensen; Jan Ravkilde; Per Thayssen; Søren Galatius; Evald Høj Christiansen; Thomas Engstrøm; Morten Vesterager Madsen; Leif Thuesen; Hans Henrik Tilsted

doi:10.1186/1471-2261-12-18

Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)

Troels Thim, Michael Maeng, Jens Flensted Lassen, Anne Kjer Kaltoft, Lisette Okkels Jensen, Jan Ravkilde, Per Thayssen, Søren Galatius, Evald Høj Christiansen, Thomas Engstrøm, Morten Vesterager Madsen, Leif Thuesen, Hans Henrik Tilsted

Research output: Contribution to journal › Journal article › Research › peer-review

Abstract

Data on clinical outcomes among patients treated with the zotarolimus-eluting Endeavor™ stent versus the sirolimus-eluting Cypher™ stent favor the sirolimus-eluting stent. However, a separate comparison of clinical outcome among patients treated for multiple lesions with these stents is lacking. We performed this comparison within the SORT OUT III trial data set.

Original language	English
Journal	B M C Cardiovascular Disorders
Volume	12
Pages (from-to)	18
ISSN	1471-2261
DOIs	https://doi.org/10.1186/1471-2261-12-18
Publication status	Published - 2012

Access to Document

10.1186/1471-2261-12-18

Library access?

Check availability at the Royal Danish Library

Cite this

Thim, T., Maeng, M., Lassen, J. F., Kaltoft, A. K., Jensen, L. O., Ravkilde, J., Thayssen, P., Galatius, S., Christiansen, E. H., Engstrøm, T., Madsen, M. V., Thuesen, L., & Tilsted, H. H. (2012). Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy). B M C Cardiovascular Disorders, 12, 18. https://doi.org/10.1186/1471-2261-12-18

Thim, T, Maeng, M, Lassen, JF, Kaltoft, AK, Jensen, LO, Ravkilde, J, Thayssen, P, Galatius, S, Christiansen, EH, Engstrøm, T, Madsen, MV, Thuesen, L & Tilsted, HH 2012, 'Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)', B M C Cardiovascular Disorders, vol. 12, pp. 18. https://doi.org/10.1186/1471-2261-12-18

@article{aebd9c0619744761bd0302a7e7d90eb9,

title = "Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)",

abstract = "Data on clinical outcomes among patients treated with the zotarolimus-eluting Endeavor{\texttrademark} stent versus the sirolimus-eluting Cypher{\texttrademark} stent favor the sirolimus-eluting stent. However, a separate comparison of clinical outcome among patients treated for multiple lesions with these stents is lacking. We performed this comparison within the SORT OUT III trial data set.",

author = "Troels Thim and Michael Maeng and Lassen, {Jens Flensted} and Kaltoft, {Anne Kjer} and Jensen, {Lisette Okkels} and Jan Ravkilde and Per Thayssen and S{\o}ren Galatius and Christiansen, {Evald H{\o}j} and Thomas Engstr{\o}m and Madsen, {Morten Vesterager} and Leif Thuesen and Tilsted, {Hans Henrik}",

year = "2012",

doi = "10.1186/1471-2261-12-18",

language = "English",

volume = "12",

pages = "18",

journal = "B M C Cardiovascular Disorders",

issn = "1471-2261",

publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)

AU - Thim, Troels

AU - Maeng, Michael

AU - Lassen, Jens Flensted

AU - Kaltoft, Anne Kjer

AU - Jensen, Lisette Okkels

AU - Ravkilde, Jan

AU - Thayssen, Per

AU - Galatius, Søren

AU - Christiansen, Evald Høj

AU - Engstrøm, Thomas

AU - Madsen, Morten Vesterager

AU - Thuesen, Leif

AU - Tilsted, Hans Henrik

PY - 2012

Y1 - 2012

N2 - Data on clinical outcomes among patients treated with the zotarolimus-eluting Endeavor™ stent versus the sirolimus-eluting Cypher™ stent favor the sirolimus-eluting stent. However, a separate comparison of clinical outcome among patients treated for multiple lesions with these stents is lacking. We performed this comparison within the SORT OUT III trial data set.

AB - Data on clinical outcomes among patients treated with the zotarolimus-eluting Endeavor™ stent versus the sirolimus-eluting Cypher™ stent favor the sirolimus-eluting stent. However, a separate comparison of clinical outcome among patients treated for multiple lesions with these stents is lacking. We performed this comparison within the SORT OUT III trial data set.

U2 - 10.1186/1471-2261-12-18

DO - 10.1186/1471-2261-12-18

M3 - Journal article

C2 - 22429474

SN - 1471-2261

VL - 12

SP - 18

JO - B M C Cardiovascular Disorders

JF - B M C Cardiovascular Disorders

ER -